INFUSION SITE HYPERTROPHY

This adverse event was reported 28 times

These drugs are most commonly taken by patients reporting INFUSION SITE HYPERTROPHY:

# Drug Count
0 FOSCARBIDOPA/FOSLEVODOPA 21
1 OPICAPONE 4
2 FOLIC ACID 3
3 QUETIAPINE 3
4 RASAGILINE MESYLATE 3
5 ROTIGOTINE 3
6 TREPROSTINIL 3
7 AMANTADINE 2
8 AMBRISENTAN 2
9 APIXABAN 2
See all common drugs associated with INFUSION SITE HYPERTROPHY

INFUSION SITE HYPERTROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FOSCARBIDOPA/FOSLEVODOPA 21 0.0024
1 OPICAPONE 4 0.0016
2 IODIXANOL 1 0.0003
3 RASAGILINE MESYLATE 3 0.0003
4 MIDODRINE HYDROCHLORIDE 1 0.0002
5 ROTIGOTINE 3 0.0002
6 KETAMINE HYDROCHLORIDE 1 0.0002
7 AMANTADINE 2 0.0002
8 ROPINIROLE 2 0.0001
9 METHIMAZOLE 1 0.0001
See all drugs enriched for association with INFUSION SITE HYPERTROPHY